Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.18%
#3 CoW Protocol CoW Protocol +44.40%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +26.78%
#6 Walrus Walrus +24.24%
#7 Codatta Codatta +19.91%
#8 Enso Enso +18.69%
#9 Collector Crypt Collector Crypt +14.14%
#10 The Black Bull The Black Bull +13.35%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
주식 순위 #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
주가
$0.117
마지막 동기화: 2025-04-04
시가총액
$2.45M
변동 (1일)
-13.59%
변동 (1년)
0.00%
국가
US
거래 Carmell Therapeutics Corporation (CTCX)

카테고리

Healthcare
Carmell Therapeutics Corporation (CTCX)의 매출
Jun 2026 기준 매출 TTM: $1.69M
Carmell Therapeutics Corporation의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $1.69M입니다. 2023년에 회사는 0.00의 수익을 올렸으며 이는 2022년의 0.00 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Carmell Therapeutics Corporation의 수익 기록 (2021 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $1.69M 3,251.88%
2024 $50.32K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 748,405.43%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 356,907.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 599,377.10%
BE